<DOC>
	<DOC>NCT01014429</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.</brief_summary>
	<brief_title>Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Advanced/metastatic solid tumors, for which no effective standard therapy exist Adult patients (age &gt;/= 18) ECOG performance status (PS) 0 or 1 Life expectancy of at least 3 months Adequate renal, liver function and bone marrow reserve Prior cancer therapy allowed, with max 4 regimens of chemotherapy. Washout: at least 4 wks (6 wks for nitrosoureas, mitomycin C and liposomal doxorubicin) and all toxicities recovered to CTC Grade &lt;/=1 Prior radiotherapy allowed if no more than 25% of BM reserve irradiated Women and men of child producing potential should agree to use effective contraception Capability to swallow capsules intact Known uncontrolled/symptomatic brain metastases Currently active second malignancy Major surgery in the last 4 wks Any of the following in the past 6 months: myocardial infarction, unstable angina, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, cerebrovascular accident or transient ischemic attack, pulmonary embolism, deep vein thrombosis Pregnancy or breastfeeding women Known active infections History of drug allergic reactions Gastrointestinal disease or other malabsorption syndromes that would impact on drug absorption. Documented gastrointestinal ulcer Other severe concurrent acute or chronic medical or psychiatric condition that could compromise protocol objectives</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Phase I dose escalation study</keyword>
	<keyword>Advanced or metastatic solid tumors</keyword>
	<keyword>PLK 1 inhibitor</keyword>
	<keyword>Adult patients</keyword>
</DOC>